Earnings Preview: Revance Therapeutics
Portfolio Pulse from Benzinga Insights
Revance Therapeutics (NASDAQ:RVNC) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.77. The company's past performance shows a pattern of share price drops following earnings misses. The stock is currently trading at $22.75, up 28.79% over the last 52-week period.
August 07, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Revance Therapeutics is expected to report an EPS of $-0.77. Past performance shows a trend of share price drops following earnings misses. The stock is currently trading at $22.75, up 28.79% over the last 52-week period.
Given the company's history of share price drops following earnings misses, and the analysts' estimate of a negative EPS, the short-term impact on the stock price is likely to be negative. However, the stock has shown a positive trend over the last 52-week period.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100